Rbf Capital, LLC Atea Pharmaceuticals, Inc. Transaction History
Rbf Capital, LLC
- $1.87 Billion
- Q4 2024
A detailed history of Rbf Capital, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Rbf Capital, LLC holds 54,929 shares of AVIR stock, worth $166,434. This represents 0.01% of its overall portfolio holdings.
Number of Shares
54,929
Previous 148,451
63.0%
Holding current value
$166,434
Previous $497,000
62.98%
% of portfolio
0.01%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding AVIR
# of Institutions
112Shares Held
50.9MCall Options Held
7.6KPut Options Held
38.7K-
Black Rock Inc. New York, NY9.12MShares$27.6 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$23.1 Million15.83% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$14.5 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$14.1 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.34MShares$10.1 Million0.52% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $252M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...